Regularly Updated Micro Charts with Target Boxes starting from $24.99/month XBI – reaffirm my bearish expectation for a drop to $60 – $50. XBI is the SPDR® S&P® Biotech ETF seeks to provide investment results that correspond to the performance of the S&P® Biotechnology Select IndustryTM Index. On November 9th 2018 I posted a Read more…
XBI – may drop to $60 – 50 XBI is the SPDR® S&P® Biotech ETF seeks to provide investment results that correspond to the performance of the S&P® Biotechnology Select IndustryTM Index. To complete a large corrective wave ( B ) down off the top reached in June 2018 we should get another impulsive Read more…
XBI – either has bottomed or needs one more low Biotech ETF seeks to provide investment results corresponding to the total return performance of the S&P Biotechnology Select Index. XBI topped in June 2018. Off that top we got an impulsive looking decline clearly subdivided into five waves. At this Read more…